It is only known that the stimulation of GPR34 enhances the malignancy and carcinogenesis of glioma by promoting an epithelial-mesenchymal transition, G1/S phase cell cycle transition, and TGF-beta/Smad signaling [109]. The gene discussed is GPR34; the disease is glioma.